Abstract:Y. Ai, S. Wu, H. Gao, H. Wei, Z. Tang, X. Li, and C. Zou, "Repression of CRNDE Enhances the Anti-Tumour Activity of CD8+ T Cells Against Oral Squamous Cell Carcinoma Through Regulating Mir-545-5p and TIM-3," Journal of Cellular and Molecular Medicine 25, no. 23 (2021): 10857-10868, https://doi.org/10.1111/jcmm.16909. The above article, published online on 02 November 2021 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stefan Constantinescu; The Foundation for Cellular and Molecular Medicine; and John Wiley and Sons Ltd. The retraction has been agreed following an investigation into concerns raised by a third party, which revealed inappropriate duplications of image panels (Figures 4C,D, 6B and 7B) between this and other articles that were previously published in a different scientific context. The authors were unable to provide a satisfactory explanation, and the provided raw data could not explain the identified issues. Thus, the editors consider the conclusions of this manuscript substantially compromised. The authors were informed of the decision to retract but did not respond to the retraction decision or the wording.

Retraction: Cell Membrane Based Biomimetic Nanocomposites for Targeted Therapy of Drug Resistant EGFR-mutated Lung Cancer

Circ0021205 Aggravates the Progression of Non-Small Cell Lung Cancer by Targeting Mirna-16-5p/vegfa

MiR-30 Suppresses Lung Cancer Cell 95D Epithelial Mesenchymal Transition and Invasion Through Targeted Regulating Snail.

Retraction: Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer

Cell membrane based biomimetic nanocomposites for targeted therapy of drug resistant EGFR-mutated lung cancer

Retraction of “Overcoming Ovarian Cancer Drug Resistance with a Cold Responsive Nanomaterial”

RETRACTION: An MSN-PEG-IP drug delivery system and IL13R2 as targeted therapy for glioma (Retraction of Vol 9, Pg 8970, 2017)

RETRACTION: Radio-photothermal Therapy Mediated by a Single Compartment Nanoplatform Depletes Tumor Initiating Cells and Reduces Lung Metastasis in the Orthotopic 4T1 Breast Tumor Model (retraction of Vol 7, Pg 19438, 2015)

Retraction: an MSN-PEG-IP Drug Delivery System and IL13Rα2 As Targeted Therapy for Glioma.

Retracted: Observation of the Curative Effect of Acupuncture for Tonifying Kidney and Removing Blood Stasis Combined with Radiofrequency Surgery in Patients with NSCLC and the Diagnostic Efficacy of Combined Detection of NTx, BGP, and CYFRA21-1 in the Occurrence of Bone Metastases

Retraction: PEG-poly(amino acid)s/EpCAM aptamer multifunctional nanoparticles arrest the growth and metastasis of colorectal cancer

Retraction notice to "A DNA-based nanocarrier for efficient cancer therapy" [J. Pharm. Anal. 11 (2021) 330-339]

Correction: The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer

Erratum To: Biological Evaluation of Antibody-Maytansinoid Conjugates As a Strategy of RON Targeted Drug Delivery for Treatment of Non-Small Cell Lung Cancer

Retraction: Radio-photothermal therapy mediated by a single compartment nanoplatform depletes tumor initiating cells and reduces lung metastasis in the orthotopic 4T1 breast tumor model.

Retracted: Arsenic Trioxide Inhibits the Metastasis of Small Cell Lung Cancer by Blocking Calcineurin-Nuclear Factor of Activated T Cells (NFAT) Signaling

Nanomodified strategies to overcome EGFR-tyrosine kinase inhibitors resistance in non-small cell lung cancer

RETRACTED ARTICLE: Nanoformulation of Apolipoprotein E3-Tagged Liposomal Nanoparticles for the co-Delivery of KRAS-siRNA and Gemcitabine for Pancreatic Cancer Treatment

RETRACTION: Repression of CRNDE Enhances the Anti-Tumour Activity of CD8 + T Cells Against Oral Squamous Cell Carcinoma Through Regulating Mir-545-5p and TIM-3

Corrigendum: EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy As First-Line Therapy for Non-Small Cell Lung Cancer Patients with the L858R Point Mutation.

Correction to "α 3 β 1 Integrin-Targeting Polymersomal Docetaxel as an Advanced Nanotherapeutic for Nonsmall Cell Lung Cancer Treatment"